These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 807459)

  • 1. Orally-administered silver sulfadiazine: chemotherapy and toxicology in CF-1 mice; Plasmodium berghei (Malaria) and Pseudomonas aeruginosa.
    Wysor MS
    Chemotherapy; 1975; 21(5):302-10. PubMed ID: 807459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarials: screening of (orally administered) silver solfonamides against Plasmodium berghei.
    Wysor MS
    Chemotherapy; 1975; 21(5):284-8. PubMed ID: 1098869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preparation and invivo use of silver sulphadiazine cream for treatment of burns infected with Pseudomonas aeruginosa.
    Drake DJ; Froese EH
    Cent Afr J Med; 1975 Apr; 21(4):71-2. PubMed ID: 806345
    [No Abstract]   [Full Text] [Related]  

  • 4. Zinc sulfadiazine for topical therapy of pseudomonas infection in burns.
    Fox CL; Modak SM; Stanford JW
    Surg Gynecol Obstet; 1976 Apr; 142(4):553-9. PubMed ID: 816019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
    Modak SM; Fox CL
    Arch Surg; 1981 Jul; 116(7):854-7. PubMed ID: 6455105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of supraeschar and subeschar Pseudomonas infection by silver sulfadiazine dry foam.
    Catania PN; King JC
    J Pharm Sci; 1975 Mar; 64(3):457-8. PubMed ID: 807702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of burn wound infections by pefloxacin and its silver derivative.
    Modak S; Stanford J; Friedlaender J; Fox P; Fox CL
    Burns Incl Therm Inj; 1984 Feb; 10(3):170-8. PubMed ID: 6586256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns.
    Fox CL
    Arch Surg; 1968 Feb; 96(2):184-8. PubMed ID: 5638080
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns.
    Stanford W; Rappole BW; Fox CL
    J Trauma; 1969 May; 9(5):377-88. PubMed ID: 5771755
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of silver lactate and silver sulfadiazine on experimental burn wound sepsis.
    Cossman DV; Krizek TJ
    Surg Forum; 1971; 22():495-7. PubMed ID: 5121452
    [No Abstract]   [Full Text] [Related]  

  • 11. Virulence of Pseudomonas infection in burned rats and mice. Comparative efficacy of silver sulfadiazine and mafenide.
    Fox CL; Sampath AC; Stanford JW
    Arch Surg; 1970 Oct; 101(4):508-12. PubMed ID: 4989718
    [No Abstract]   [Full Text] [Related]  

  • 12. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
    Ishih A; Miyase T; Ohori K; Terada M
    Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo antimalarial activities of Enantia polycarpa stem bark against Plasmodium berghei berghei in mice.
    Anosa GN; Udegbunam RI; Okoro JO; Okoroafor ON
    J Ethnopharmacol; 2014 Apr; 153(2):531-4. PubMed ID: 24561382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic, patent Plasmodium berghei malaria in splenectomized mice.
    Eling WM
    Infect Immun; 1982 Mar; 35(3):880-6. PubMed ID: 7040249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activities of silver sulfadiazine in ocular infection.
    Tokumaru T; Shimizu Y; Fox CL
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):151-8. PubMed ID: 4368031
    [No Abstract]   [Full Text] [Related]  

  • 16. Malaria immunity and premunition in a Plasmodium berghei mouse model.
    Eling WM
    Isr J Med Sci; 1978 May; 14(5):542-53. PubMed ID: 355189
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined use of topical cyclosporin A and silver sulphadiazine on allografts infected with Pseudomonas in burned rats.
    Lai CS; Miskell P; Gonce SJ; Alexander JW; Babcock GF
    Burns Incl Therm Inj; 1987 Jun; 13(3):181-4. PubMed ID: 3111646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silver phosphanilamidopyrimidine. A new silver sulfadiazine analogue effective against Pseudomonas infection in burned mice.
    Wysor MS; Zollinhofer RE
    Chemotherapy; 1973; 18(6):342-7. PubMed ID: 4200356
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental burn wound sepsis: variations in response to topical agents.
    Krizek TJ; Cossman DV
    J Trauma; 1972 Jul; 12(7):553-62. PubMed ID: 4625533
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimalarial activity of Floxacrine (HOE 991) I. Studies on blood schizontocidal action of Floxacrine against Plasmodium berghei, P. vinckei and P. cynomolgi.
    Raether W; Fink E
    Ann Trop Med Parasitol; 1979 Dec; 73(6):505-26. PubMed ID: 120142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.